CAPR
Price
$14.23
Change
+$1.05 (+7.97%)
Updated
Jun 6 closing price
Capitalization
602.43M
59 days until earnings call
CORT
Price
$69.60
Change
+$0.59 (+0.85%)
Updated
Jun 6 closing price
Capitalization
7.32B
51 days until earnings call
Interact to see
Advertisement

CAPR vs CORT

Header iconCAPR vs CORT Comparison
Open Charts CAPR vs CORTBanner chart's image
Capricor Therapeutics
Price$14.23
Change+$1.05 (+7.97%)
Volume$2.51M
Capitalization602.43M
Corcept Therapeutics
Price$69.60
Change+$0.59 (+0.85%)
Volume$973.29K
Capitalization7.32B
CAPR vs CORT Comparison Chart
Loading...
CAPR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CORT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CAPR vs. CORT commentary
Jun 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CAPR is a StrongBuy and CORT is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 09, 2025
Stock price -- (CAPR: $10.65 vs. CORT: $77.65)
Brand notoriety: CAPR and CORT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CAPR: 41% vs. CORT: 78%
Market capitalization -- CAPR: $602.43M vs. CORT: $7.32B
CAPR [@Biotechnology] is valued at $602.43M. CORT’s [@Biotechnology] market capitalization is $7.32B. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CAPR’s FA Score shows that 0 FA rating(s) are green whileCORT’s FA Score has 2 green FA rating(s).

  • CAPR’s FA Score: 0 green, 5 red.
  • CORT’s FA Score: 2 green, 3 red.
According to our system of comparison, CORT is a better buy in the long-term than CAPR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CAPR’s TA Score shows that 6 TA indicator(s) are bullish while CORT’s TA Score has 4 bullish TA indicator(s).

  • CAPR’s TA Score: 6 bullish, 4 bearish.
  • CORT’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, CAPR is a better buy in the short-term than CORT.

Price Growth

CAPR (@Biotechnology) experienced а -4.23% price change this week, while CORT (@Biotechnology) price change was +2.44% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

CAPR is expected to report earnings on Aug 07, 2025.

CORT is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CORT($7.32B) has a higher market cap than CAPR($602M). CORT YTD gains are higher at: 54.098 vs. CAPR (-22.826). CORT has higher annual earnings (EBITDA): 138M vs. CAPR (-34.79M). CORT has more cash in the bank: 383M vs. CAPR (85M). CAPR has less debt than CORT: CAPR (1.65M) vs CORT (6.94M). CORT has higher revenues than CAPR: CORT (675M) vs CAPR (23.2M).
CAPRCORTCAPR / CORT
Capitalization602M7.32B8%
EBITDA-34.79M138M-25%
Gain YTD-22.82654.098-42%
P/E RatioN/A60.04-
Revenue23.2M675M3%
Total Cash85M383M22%
Total Debt1.65M6.94M24%
FUNDAMENTALS RATINGS
CAPR vs CORT: Fundamental Ratings
CAPR
CORT
OUTLOOK RATING
1..100
1111
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
84
Overvalued
PROFIT vs RISK RATING
1..100
7632
SMR RATING
1..100
9841
PRICE GROWTH RATING
1..100
6437
P/E GROWTH RATING
1..100
1006
SEASONALITY SCORE
1..100
n/a47

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CAPR's Valuation (76) in the Biotechnology industry is in the same range as CORT (84) in the Pharmaceuticals Other industry. This means that CAPR’s stock grew similarly to CORT’s over the last 12 months.

CORT's Profit vs Risk Rating (32) in the Pharmaceuticals Other industry is somewhat better than the same rating for CAPR (76) in the Biotechnology industry. This means that CORT’s stock grew somewhat faster than CAPR’s over the last 12 months.

CORT's SMR Rating (41) in the Pharmaceuticals Other industry is somewhat better than the same rating for CAPR (98) in the Biotechnology industry. This means that CORT’s stock grew somewhat faster than CAPR’s over the last 12 months.

CORT's Price Growth Rating (37) in the Pharmaceuticals Other industry is in the same range as CAPR (64) in the Biotechnology industry. This means that CORT’s stock grew similarly to CAPR’s over the last 12 months.

CORT's P/E Growth Rating (6) in the Pharmaceuticals Other industry is significantly better than the same rating for CAPR (100) in the Biotechnology industry. This means that CORT’s stock grew significantly faster than CAPR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CAPRCORT
RSI
ODDS (%)
Bullish Trend 12 days ago
88%
N/A
Stochastic
ODDS (%)
Bearish Trend 12 days ago
86%
Bearish Trend 12 days ago
68%
Momentum
ODDS (%)
Bullish Trend 12 days ago
81%
Bullish Trend 12 days ago
73%
MACD
ODDS (%)
Bullish Trend 12 days ago
82%
Bullish Trend 12 days ago
72%
TrendWeek
ODDS (%)
Bearish Trend 12 days ago
85%
Bullish Trend 12 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 12 days ago
83%
Bullish Trend 12 days ago
77%
Advances
ODDS (%)
Bullish Trend 12 days ago
85%
Bullish Trend 24 days ago
80%
Declines
ODDS (%)
Bearish Trend about 1 month ago
85%
Bearish Trend about 1 month ago
66%
BollingerBands
ODDS (%)
Bullish Trend 12 days ago
88%
Bearish Trend 12 days ago
73%
Aroon
ODDS (%)
N/A
Bullish Trend 12 days ago
73%
View a ticker or compare two or three
Interact to see
Advertisement
CAPR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CORT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

CAPR and

Correlation & Price change

A.I.dvisor tells us that CAPR and WVE have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CAPR and WVE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CAPR
1D Price
Change %
CAPR100%
+1.62%
WVE - CAPR
31%
Poorly correlated
+1.85%
XNCR - CAPR
31%
Poorly correlated
-2.58%
CCCC - CAPR
31%
Poorly correlated
-3.08%
NKTR - CAPR
30%
Poorly correlated
+3.68%
CORT - CAPR
30%
Poorly correlated
+1.09%
More

CORT and

Correlation & Price change

A.I.dvisor indicates that over the last year, CORT has been loosely correlated with DNLI. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if CORT jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CORT
1D Price
Change %
CORT100%
+1.09%
DNLI - CORT
40%
Loosely correlated
-1.29%
TENX - CORT
38%
Loosely correlated
+0.33%
ARCT - CORT
38%
Loosely correlated
-1.75%
HNSBF - CORT
38%
Loosely correlated
N/A
INSM - CORT
34%
Loosely correlated
-2.44%
More